AGF Investments Inc’s AstraZeneca AZN Stock Holding History

AGF Investments Inc’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-119	Closed	-$14K	–	447
2021 Q4	$14K	Hold	119	–	–	﹤0.01%	681
2021 Q3	$14K	Buy	119 +15	+14%	+$1.75K	﹤0.01%	685
2021 Q2	$12K	Buy	104 +42	+68%	+$4.61K	﹤0.01%	697
2021 Q1	$6K	Buy	+62	New	+$6.23K	﹤0.01%	722
2019 Q2	–	Sell	-62,936	Closed	-$5.09M	–	337
2019 Q1	$5.09M	Buy	62,936 +25,436	+68%	+$2M	0.06%	189
2018 Q4	$2.85M	Buy	+37,500	New	+$2.93M	0.03%	226

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

AGF Investments Inc's AZN Position: Q1 2022 in Review

AGF Investments Inc sold out of AstraZeneca (AZN) in Q1 2022, closing a stake of 119 shares — an estimated $14K sold.

AGF Investments Inc first reported a position in AZN in Q4 2018 and held it in 6 quarters. The position peaked at $5.09M in Q1 2019. 982 funds tracked by Wall St. Rank hold AZN as of Q1 2022.

AGF Investments Inc reported no remaining AstraZeneca position as of Q1 2022 after selling out during the quarter.
AGF Investments Inc sold 119 AstraZeneca shares in Q1 2022, an estimated $14K.
AGF Investments Inc first reported a position in AstraZeneca in Q4 2018 and held it in 6 quarters.
AGF Investments Inc's AstraZeneca position peaked at $5.09M in Q1 2019.
982 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2022.

Based on AGF Investments Inc's 13F filing for Q1 2022, filed 10 May 2022.